Skip to content
  • Contact Us
  • Request Samples
  • Order
Mill Creek Life Sciences
  • Our Technology
    • Human Platelet Lysate
    • Applications
    • Dendritic Cell Vaccine
  • Products
    • PLTMax® & PLTMax®-GI
    • PLTGold® & PLTGold®-GI
    • Pathogen Inactivated
    • Order
    • Request Samples
  • Support
    • Technical Support
    • Publications
    • Posters
    • Distributors
    • FAQs
    • Contact Us
  • About Us
    • Our Company
    • Quality
    • News
    • Collaborate
    • Careers
Filters (14)
Filters
  • Reset all ×
  • Tissue repair ×
  • Bone and Cartilage ×
  • Heart ×
  • Nerve System / Tissue ×
  • 2011 ×
  • 2013 ×
  • 2015 ×
  • 2016 ×
  • 2017 ×
  • 2018 ×
  • 2020 ×
  • 2021 ×
  • 2022 ×

14 resources found

Show (14)
Cancel

Hydrogel supplemented with human platelet lysate enhances multi-lineage differentiation of mesenchymal stem cells (Apr 2022)

Human meniscus allograft augmentation by allogeneic mesenchymal stromal/stem cell injections (Mar 2022)

Light chain amyloidosis induced inflammatory changes in cardiomyocytes and adipose-derived mesenchymal stromal cells (May 2020)

CELLTOP Clinical Trial: First Report From a Phase 1 Trial of Autologous Adipose Tissue Derived Mesenchymal Stem Cells in the Treatment of Paralysis Due to Traumatic Spinal Cord Injury (Feb 2020)

The effect of human platelet lysate on corneal nerve regeneration (Jun 2021)

Osteogenic Stimulation of Human Adipose-Derived Mesenchymal Stem Cells Using a Fungal Metabolite That Suppresses the Polycomb Group Protein EZH2 (Feb 2018)

Mesenchymal stromal cells protect human cardiomyocytes from amyloid fibril damage (Dec 2017)

Molecular Validation of Chondrogenic Differentiation and Hypoxia Responsiveness of Platelet-Lysate Expanded Adipose Tissue–Derived Human Mesenchymal Stromal Cells (Jul 2017)

Safety Studies for Use of Adipose Tissue-Derived Mesenchymal Stromal/Stem Cells in a Rabbit Model for Osteoarthritis to Support a Phase I Clinical Trial (Mar 2017)

Melatonin-micronutrients Osteopenia Treatment Study (MOTS): a translational study assessing melatonin, strontium (citrate), vitamin D3 and vitamin K2 (MK7) on bone density, bone marker turnover and health related quality of life in postmenopausal osteopenic women following a one-year double-blind RCT and on osteoblast-osteoclast co-cultures (Jan 2017)

Safety of intrathecal autologous adipose-derived mesenchymal stromal cells in patients with ALS (Nov 2016)

Osteogenic potential of human adipose-tissue derived mesenchymal stromal cells cultured on 3D-printed porous structured titanium (May 2016)

Tracking and Therapeutic Value of Human Adipose Tissue– derived Mesenchymal Stem Cell Transplantation in Reducing Venous Neointimal Hyperplasia (May 2016)

A Safety Study on Intrathecal Delivery of Autologous Mesenchymal Stromal Cells in Rabbits Directly Supporting Phase I Human Trials (May 2015)

MillCreek_Logo.rev.v

Mill Creek Life Sciences, Inc.
221 1st Avenue SW, Suite 209
Rochester, MN 55902, USA

Phone: 507-287-6257
Fax: 507-289-2066
Email: info@millcreekls.com

LinkedIn Facebook Twitter Email

OUR TECHNOLOGY

Human Platelet Lysate

Applications

Dendritic Cell Vaccine

PRODUCTS

PLTMax®

PLTGold®

Pathogen Inactivated

Order

Request Samples

SUPPORT

Technical Support

Publications

Posters

Distributors

FAQs

Contact Us

ABOUT US

Our Company

Quality

News

Collaborate

Careers